We investigated whether constitutive PLCγ2/IP3 signaling occurs in B-cell cancer models and whether this contributes to survival and BIRD-2 sensitivity in DLBCL with elevated IP3R2-expression levels. Here, PLCG2 is linked to diffuse large B-cell lymphoma.